MEKK3 Antibody (Rabbit mAb) [G24J6]

Catalog No.: F5043

    Application: Reactivity:
    • Lane 1: HEL, Lane 2: Jurkat, Lane 3: K562, Lane 4: NIH/3T3
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat, Monkey
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    71 kDa
    ポジティブコントロール HeLa cells; HEL cells; Jurkat cells; K-562 cells; SK-N-AS cells; NIH/3T3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    MEKK3 Antibody (Rabbit mAb) [G24J6] detects endogenous levels of total MEKK3 protein.
    Uniprot ID
    Q99759
    Clone
    G24J6
    Synonym(s)
    M3K3; MAP/ERK kinase kinase 3; MAP3K3; MAPK/ERK kinase kinase 3; MAPKKK3; MEK kinase 3; MEKK 3; MEKK3; Mitogen-activated protein kinase kinase kinase 3
    Background
    MEKK3 (MAP3K3) is a serine/threonine MAP kinase kinase kinase that integrates inflammatory, mechanical, and growth factor inputs to activate multiple downstream kinase cascades and transcriptional programs, with particularly prominent roles in ERK5/BMK1 signaling, NF‑κB activation, and vascular and immune homeostasis. The protein contains an N‑terminal PB1 domain that mediates heterotypic PB1–PB1 interactions with MEK5 and adaptor proteins such as p62, a central catalytic kinase domain with an activation loop harboring regulatory serine/threonine residues, and a C‑terminal regulatory tail that participates in protein–protein interactions and subcellular targeting, creating a scaffold that supports assembly of MEKK3–MEK5–ERK5 modules and NF‑κB upstream complexes. MEKK3 directly phosphorylates and activates MEK5, which in turn activates ERK5/BMK1 in response to growth factors and stress, establishing the canonical MEKK3–MEK5–ERK5 axis that controls endothelial cell survival, shear stress responses, and mitochondrial quality control; this pathway is required for basal mitochondrial degradation in the absence of exogenous damage and contributes to maintenance of mitochondrial homeostasis. In parallel, MEKK3 functions as an upstream activator of NF‑κB in response to TNFα, IL‑1, LPS, lysophosphatidic acid, and other stimuli by phosphorylating and activating IKK complexes, leading to IκB degradation, nuclear translocation of RelA/p50, and induction of pro‑survival and pro‑inflammatory genes, and genetic or pharmacologic interference with MEKK3 reduces NF‑κB activity and sensitizes cancer cells to apoptosis. MEKK3 also contributes to activation of JNK and p38 MAPKs under certain stress conditions, positioning it as a nodal MAP3K that can feed into SAPK, ERK1/2, p38, and ERK5 branches depending on cellular context and adaptor usage, and it participates in crosstalk with Akt, which phosphorylates MEKK3 and promotes association with 14‑3‑3 proteins to modulate its activity in vascular smooth muscle and other cell types. Structural and functional analyses show that MEKK3 interacts directly with the cerebral cavernous malformation protein CCM2 through a defined interface, forming a signaling complex that is essential for embryonic angiogenesis and blood–brain barrier integrity and whose disruption leads to increased RhoA/ROCK activity, vascular malformations, and cerebral cavernous angiomas, highlighting MEKK3 as a critical mediator of endothelial responses to hemodynamic forces and CCM signaling. MEKK3 and its close relative MEKK2 also regulate the Hippo pathway by controlling upstream inputs to MST1/2 and LATS1/2 and thereby influencing YAP/TAZ activity, revealing an additional layer where MEKK3‑dependent MAPK signaling intersects with organ size control and oncogenic transcriptional coactivators. Dysregulated MEKK3 expression and activation have been reported in several cancers, including ovarian and renal clear cell carcinoma, where high MEKK3 levels correlate with elevated IKK/NF‑κB activity, increased expression of anti‑apoptotic genes, and drug resistance, and paclitaxel‑induced stress signals require functional MEKK3 to activate JNK/p38 pathways and influence chemotherapeutic responses.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください